Pioglitazone

Hmm… We’d better think about this again. Pioglitazone is not a good first‑line choice because it causes weight gain and fluid retention and it lacks clear cardiovascular outcome benefits. If a thiazolidinedione is considered at all, it is considered in cases where first line drugs are not indicated or unavailable, or in combination with other first line drugs.

Try to think about other drugs with favourable weight and cardiovascular profiles. Always consider the full clinical context when prescribing medications and try again!

  • History of Allergies [undo]
  • Mechanism of action of PPIs [undo]
  • DNA Amplification [undo]
  • Increased entry of fatty acids into adipocytes [undo]
  • Αξονική τομογραφία [undo]
  • Clinical examination [undo]
  • No ayudará a su madre. [undo]
  • Presentation [undo]
  • History of Medications [undo]
  • Insist on continuing with poor video quality [undo]
  • HeLa cells are naturally resistant to all drugs. [undo]
  • Bazați-vă exclusiv pe trăsături fizice și săriți peste orice analiză cromozomială [undo]
  • Increased secretion of insulin from the pancreas [undo]
  • Decreased production of glucose from the liver [undo]
  • Presentation [undo]
  • Amplificación del ADN [undo]
  • Decreased entry of glucose into muscle cells [undo]
  • START [undo]
  • Start [undo]
  • Secvențierea genomului [undo]
  • Se îmbrățișează și se consolează reciproc. [undo]
  • Definiciones básicas sobre enzimas [undo]
  • Cariotipul [undo]
  • Ayudará a su madre. [undo]
  • Privacy risk [undo]
  • Furosemide (loop diuretic) [undo]
  • Mental Status [undo]
  • Pioglitazone [undo]

Map: Michael Green_GEMD_2 (1116)
Node: 21115
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway